Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
Sponsor
Tepecik Training and Research Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04135274
Collaborator
(none)
57
47.9
Study Details
Study Description
Brief Summary
We aimed to investigate whether Neutrophil Lymphocyte Ratio is a Prognostic Factor of Sepsis in Newborns with operated Neural Tube Defects?
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational [Patient Registry]
Actual Enrollment
:
57 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Neural Tube Defects?
Actual Study Start Date
:
Jan 1, 2015
Actual Primary Completion Date
:
Dec 30, 2018
Actual Study Completion Date
:
Dec 30, 2018
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Sepsis group
|
Diagnostic Test: Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio
|
| Non Sepsis group
|
Diagnostic Test: Neutrophil to lymphocyte ratio
Neutrophil to lymphocyte ratio
|
Outcome Measures
Primary Outcome Measures
- Neutrophil to lymphocyte ratio is prognostic faktör for Sepsis [3 years]
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 28 Days
Sexes Eligible for Study:
All
Inclusion Criteria:
- <28 days diagnosed with with neural Tüpe Defects To be operated
Exclusion Criteria:
-
28 days
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Tepecik Training and Research Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Firat Ergin,
Medical Doctor,
Tepecik Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04135274
Other Study ID Numbers:
- 2018/12- 7
First Posted:
Oct 22, 2019
Last Update Posted:
Oct 22, 2019
Last Verified:
Oct 1, 2019
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: